Skip to main content
    S

    Supernus Pharmaceuticals, Inc. (SUPN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $29.04
    +0.21 (+0.73%)

    Market Cap: $1.52B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Supernus Pharmaceuticals, Inc. (SUPN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Supernus Pharmaceuticals (SUPN) has a latest price of $29.04 on Nov 17, 2026, 12.6% below its 52-week high of $33.22. Its price fell 35.5% over the past 12 months. The month-end price fell 64.3% over the 10 years through Oct 2026, a compound annual decline of 9.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $299.25 in Jun 2018 and its lowest $23.85 in Oct 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart SUPN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SUPN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 4.1%, and over 6 months it fell 39.0%. The month-end price rose 48.3% over the 3 years through Oct 2026, a compound annual rate of 14.0%.

    PeriodChange
    1 month+10.5%
    3 months-4.1%
    6 months-39.0%
    12 months-35.5%
    12 months, with dividends-17.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+48.3%+14.0%
    5 years-76.3%-25.0%
    10 years-64.3%-9.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 57.8%, and its weakest was 2022, when it fell 75.5%.

    YearCloseChange
    2026 through Oct 2026$35.37-28.8%
    2025$49.70+37.4%
    2024$36.16+24.9%
    2023$28.94-18.9%
    2022$35.67-75.5%
    2021$145.80+15.9%
    2020$125.80+6.1%
    2019$118.60-28.6%
    2018$166.10-16.6%
    2017$199.25+57.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 5.5% above its 50-day average of $27.54 and 24.6% below its 200-day average of $38.50.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$29.04
    52-week high$33.22-12.6%
    52-week low$21.48+35.2%
    50-day average$27.54+5.5%
    200-day average$38.50-24.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 55.8%.

    MeasureValue
    1-year beta0.54
    Largest fall, 1 year-55.3%
    Largest fall, 3 years-55.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Supernus Pharmaceuticals traded at 17.5x earnings at the end of 2025, against a 5-year median of 17.4x and a 10-year median of 54.9x.

    SUPN valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About SUPN

    What is SUPN's 1-year price change?

    Supernus Pharmaceuticals's price fell 35.5% over the past 12 months. With dividends included, the 12-month total return was -17.4%.

    What is SUPN's 5-year price change?

    Supernus Pharmaceuticals's month-end price fell 76.3% over the 5 years through Oct 2026, a compound annual decline of 25.0%. These figures leave out dividends.

    What is SUPN's 52-week high and low?

    Supernus Pharmaceuticals's 52-week high is $33.22 and its 52-week low is $21.48. Its latest price of $29.04 on Nov 17, 2026 is 12.6% below the high.

    What is SUPN's beta?

    Supernus Pharmaceuticals's 1-year beta against the S&P 500 is 0.54, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 55.3%.

    Is the SUPN chart free?

    Yes. Advanced Charting for SUPN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.